Standard Therapy Clinical Trials
8 recruitingDrug
Phase 25Phase 33Phase 11Not Applicable1
Showing 1–8 of 8 trials
Recruiting
Phase 2Phase 3
SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome
Nephrotic Syndrome
Mansoura University75 enrolled1 locationNCT07214818
Recruiting
Phase 2
A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT
Chronic Graft Versus Host DiseaseGraft vs Host Disease
WeiShi30 enrolled1 locationNCT07606703
Recruiting
Phase 2
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Breast CancerBreast NeoplasmsHER2-negative Breast Cancer+8 more
QuantumLeap Healthcare Collaborative5,000 enrolled42 locationsNCT01042379
Recruiting
Phase 1Phase 2
Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease
Fatty Liver
Tanta University50 enrolled1 locationNCT07242222
Recruiting
Not Applicable
Adaptive Therapy for Resected Stage ⅠA2-Ⅱ NSCLC Patients With Undetectable MRD
NSCLC
Peking University Cancer Hospital & Institute286 enrolled1 locationNCT06924710
Recruiting
Phase 3
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.134 enrolled1 locationNCT07150663
Recruiting
Phase 2Phase 3
Clinical Outcome of Vinpocetine in Diabetic Nephropathy
Diabetic Kidney DiseaseDiabetic Nephropathies
Ain Shams University64 enrolled2 locationsNCT06441591
Recruiting
The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.
Breast Cancer
Shengjing Hospital200 enrolled1 locationNCT05263570